Edward Kim, MD

Associate Professor

  • 1126 Citations
  • 15 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Edward Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 1126 Citations
  • 15 h-Index
  • 32 Article
  • 2 Book
  • 2 Review article
  • 1 Chapter
  • Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

    Philip, P. A., Lacy, J., Portales, F., Sobrero, A., Pazo-Cid, R., Manzano Mozo, J. L., Kim, E. J., Dowden, S., Zakari, A., Borg, C., Terrebonne, E., Rivera, F., Sastre, J., Bathini, V., López-Trabada, D., Asselah, J., Saif, M. W., Shiansong Li, J., Ong, T. J., Nydam, T. & 1 others, Hammel, P., Mar 2020, In : The Lancet Gastroenterology and Hepatology. 5, 3, p. 285-294 10 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Cancer

    Tran, N. H., Sahai, V., Griffith, K. A., Nathan, H., Kaza, R., Cuneo, K. C., Shi, J., Kim, E., Sonnenday, C. J., Cho, C. S., Lawrence, T. S. & Zalupski, M. M., Jan 1 2020, In : International Journal of Radiation Oncology Biology Physics. 106, 1, p. 124-133 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer

    Kim, R. D., McDonough, S., El-Khoueiry, A. B., Bekaii-Saab, T. S., Stein, S. M., Sahai, V., Keogh, G. P., Kim, E. J., Baron, A. D., Siegel, A. B., Barzi, A., Guthrie, K. A., Javle, M. & Hochster, H., May 2020, In : European Journal of Cancer. 130, p. 219-227 9 p.

    Research output: Contribution to journalArticle

  • Recent advances in targeted therapies for advanced gastrointestinal malignancies

    Huynh, J. C., Schwab, E., Ji, J., Kim, E., Joseph, A., Hendifar, A., Cho, M. & Gong, J., May 2020, In : Cancers. 12, 5, 1168.

    Research output: Contribution to journalReview article

    Open Access